Public health issues related to HPV vaccination.
The human papillomavirus (HPV) is clearly established as the cause of cervical cancer, and vaccines targeting oncogenic forms of the virus are important as a primary method of prevention. However, barriers to cervical screening and vaccination such as a lack of knowledge of HPV, access to healthcare, and poor follow-up prevent the acceptance and utilization of HPV vaccines. Strategies for prevention of disease and implementation of vaccination are in development, but the importance of primary prevention of HPV infection needs to be stressed. This review assesses the potential impact of vaccination for cervical cancer, barriers to vaccination, and the methods used to increase coverage. With the advent of prophylactic vaccines, HPV, a common infection in the United States, can be prevented in most women.
Hershey
Jody H
JH
New River Health District, Christiansburg, Virginia, USA. jody.hershey@vdh.virginia.gov
Velez
Luis F
LF
D000293:Adolescent; D005260:Female; D006297:Health Services Accessibility; D006801:Humans; D017589:Immunization Programs / Q000706:statistics & numerical data; D030361:Papillomavirus Infections / Q000517:prevention & control*; D053918:Papillomavirus Vaccines; D011634:Public Health; D002583:Uterine Cervical Neoplasms / Q000517:prevention & control
D053918:Papillomavirus Vaccines